1. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2019) Authors: Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Lesimple, Thierry; Plummer, Ruth; Schachter, Jacob; Dasgupta, Kohinoor; Manson, S... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus. Issue 8 (28th May 2018) Authors: Visser, Els; Edholm, David; Smithers, B. Mark; Thomson, Iain G.; Burmeister, Bryan H.; Walpole, Euan T.; Gotley, David C.; Joubert, Warren L.; Atkinson, Victoria; Mai, Tao; Thomas, Janine M.; Barbour, Andrew P. Journal: Journal of surgical oncology Issue: Volume 117:Issue 8(2018) Page Start: 1687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. Issue 3 (March 2020) Authors: Dummer, Reinhard; Brase, Jan C; Garrett, James; Campbell, Catarina D; Gasal, Eduard; Squires, Matthew; Gusenleitner, Daniel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Flaherty, Keith; Larkin, James; Robert, Caroline; Kefford, Richard; Kirkwood, John M; Hauschil... Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real‐world study. Issue 10 (21st April 2021) Authors: Yu, Su‐Yeon; Mckavanagh, Dan; McPherson, Ian; Walpole, Euan; Atkinson, Victoria; Hollingworth, Samantha Journal: Pharmacoepidemiology and drug safety Issue: Volume 30:Issue 10(2021) Page Start: 1371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II). Issue 3 (June 2020) Authors: Atkinson, Victoria; Sandhu, Shahneen; Hospers, Geke; Long, Georgina V.; Aglietta, Massimo; Ferrucci, Pier F.; Tulyte, Skaiste; Cappellini, Gian Carlo Antonini; Soriano, Virtudes; Ali, Sayed; Poprach, Alexandr; Cesas, Alvydas; Rodriguez-Abreu, Delvys; Lau, Mike; de Jong, Egbert; Legenne, Philippe;... Journal: Melanoma research Issue: Volume 30:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. (10th December 2020) Authors: Fernandez-Penas, Pablo; Carlino, Matteo; Tsai, Katy; Atkinson, Victoria; Shaheen, Monaster; Thomas, Sajeve; Mihalcioiu, Catalin; Hagen, Tom Van; Roberts-Thomson, Rachel; Haydon, Andrew; Mant, Andrew; Butler, Marcus; Daniels, Gregory; Buchbinder, Elizabeth; Hyngstrom, John; Moller, Mecker; Puzanov... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma. (November 2021) Authors: Eggermont, Alexander MM.; Meshcheryakov, Andrey; Atkinson, Victoria; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Barrow, Catherine; Di Giacomo, Anna Maria; Fisher, Rosalie; Sandhu, Shahneen; Kudchadkar, Ragini; Ortiz Romero, Pablo Luis; Svane, Inge Marie; Larkin, James; Puig, Susana; ... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Non‐sclerosing large duct cholangitis secondary to checkpoint inhibition. Issue 10 (18th October 2021) Authors: Teo, Andrew W. C.; Atkinson, Victoria; Miller, Greg; Britton, Laurence Journal: Internal medicine journal Issue: Volume 51:Issue 10(2021) Page Start: 1758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy. (4th November 2015) Authors: Prithviraj, Prashanth; McArthur, Grant; Atkinson, Victoria; Parente, Phillip; Andrews, Miles; Parakh, Sagun; Millward, Michael; Cebon, Jonathan; Klein, Oliver Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗